A view from the Center

>

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

FDA workshop on achieving medical device safety and cybersecurity: Why trustworthiness, transparency, and resilience are critical

by Steven Darroch, Senior Manager, and Nick Sikorski, Manager, Deloitte & Touche LLP, Deloitte & Touche LLP

An ever-expanding list of medical devices are able to generate, collect, analyze, and transmit data, creating the Internet of Medical Things (IoMT)—a connected infrastructure of health systems and services. As connected devices have become more common, the ability to protect digital information has become essential. Manufacturers that have a solid risk-management strategy could gain a competitive advantage.

Read more

An industry on the brink of exponential change: Health in 2040

by Doug Beaudoin, Principal, Deloitte Consulting LLP

While we don’t know with precision what the future of health might look like two decades out, we can look at signals in the market today—and disruption in other industries—to start to paint the picture.

Fundamental shifts in innovation tend to occur in seven-year cycles. By 2040, three of these cycles will have passed—each building off the other.

Read more

The future of work: Lessons from an emerging global market

by Bushra Naaz, Manager, Deloitte Center of Health Solutions

The future of work is gaining momentum in the US and across the globe. I recently attended the Future of Workplace Summit in Mumbai, India’s financial district. I was curious to hear how companies in this dynamic and fast-paced city are approaching the future of work.

The Deloitte Center of Health Solutions recently conducted research on the future of work for the US health care market.

Read more

Empowered patients, value, and digital are driving us to a new health model

by Brett J. Davis, General Manager & Principal | ConvergeHealth by Deloitte, Deloitte Consulting LLP

Five years ago—recognizing that the shift to value-based, personalized health care would have a profound and transformational impact on the industry—we launched ConvergeHEALTH. Our goal was to team up with leading health care institutions, technology companies, life sciences innovators, and patient advocacy groups to create new platforms and solutions to support this transformation for the benefit of patients.

Read more

Emerging trends in life sciences indicate cautious optimism for M&A in 2019

by Susan Dettmar, principal, US M&A consultative services leader, and Kushan Biswas, Life Sciences M&A senior manager, Deloitte Consulting LLP

Each year during the second week of January, health care executives from around the globe descend on San Francisco to discuss ground-breaking innovations, investment opportunities, and potential disruptive plays across the life sciences sector. During this year’s J.P. Morgan Healthcare Conference, we hosted a number of sessions with clients. A few topics—continued investment in oncology and gene therapies,

Read more

Unlocking the untapped potential of intelligent automation in life sciences

by Shirish Gupta, senior manager, and Muna Tuna, senior manager, Deloitte Consulting LLP

Intelligent Automation (IA)—the combination of artificial intelligence and automation—is rapidly becoming mainstream in nearly every sector of our economy. Companies are using IA to improve operational efficiencies by performing repetitive tasks far more quickly and accurately. Beyond improvements in productivity, IA also can enable higher levels of business value through innovation and strategic growth.

While industries such as financial services and retail have tapped into the potential of IA,

Read more